In her presentation, Karen Heim, VP of Alexion Canada, highlights the hidden challenges faced by rare disease patients in Canada, including diagnostic delays and treatment barriers. Key points include the five-year diagnostic journey, the role of technology in early detection, and strategies to improve access to life-changing treatments.

Real Patient Stories:

– Jennifer’s 52-year journey with hypophosphatasia
– Anthony’s breakthrough diagnosis using AI technology

Want More In-Depth Market Access Insights? Visit our comprehensive content hub: https://www.marketaccesscanada.ca/